TWST Newsletter

Give us your email address and receive the TWST Newsletter.

See the highlights of the issue right in your email box.


 

Search TWST Online

Search by ticker:
or Sector:
Search by keyword:

Subscribe to TWST

The Wall Stree Transcript is a completely unique resource for investors and business researchers. Thousands of in-depth interviews with CEOs, Industry Analysts and Professional Money Managers going back 10 years.

To obtain a copy of a TWST issue/report order online or call (212) 952-7433 .

SUBSCRIBE

Company Interview Excerpt
VINIT SAXENA - SEPRAGEN CORPORATION (SPGNA)


Full article published: 5/10/1999


For Subscribers

Get this article online now!

Order just this article
TWST: Can you give us a brief overview and a little bit of the history of the company, just to kind of set the scene for the readers?
Mr. Saxena: The company is a high technology separations company. We develop and market technology and equipment that are designed to enable our customers to separate various things from complex liquid mixtures. We have a variety of markets that we service. The first one is the biotechnology industry, wherein our products are used by biotechnology companies to isolate, to purify various biological drugs that are intended to be used in patients for therapeutic purposes. I believe eight or nine FDA approved drugs are currently using our products in the manufacturing process. Secondly, our technology is also in the dairy industry to isolate proteins from dairy whey, and thirdly our technology has exciting applications in the juice industry. As you can see, there are a number of vertical applications for our technology only a few of which have currently been developed. The company has been a development stage company and we're now transitioning into commercialization.

TWST: Who are the prime customers for your products?
Mr. Saxena: In the biotechnology industry, our customers include Baxter, Schering-Plough, Human Genome Sciences, Chiron Corporation, Glaxo-Wellcome; and a wide variety of first-tier customers. In the dairy industry, we've recently announced deals with two leading dairy ingredient suppliers of international standing. One is Anchor Products of New Zealand. Anchor, through the New Zealand Dairy Board, accounts for over 30 percent of the world export business in high end diary food ingredients, and they are a several billion dollar company. Pursuant to our agreement, Anchor will use our technology to produce certain dairy proteins, which will be extracted from whey, and will be targeted for high end uses such as differentiated infant formula, which is closer to human milk, as nutracentical supplements.

 

Tickers included in this excerpt: SPGNA

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.